Creating infrastructure for dementia research in French-speaking Africa
Official title: Building Unique Infrastructure for Large-scale Dementia research in French-Speaking Africa (BUILD-FSA) Project
Funded at University of Texas Hlth Science Center · NIH-11035847 · Data updated 2026-11-12
This study is looking to improve how we understand and treat Alzheimer's and related dementias in French-speaking Sub-Saharan Africa by working closely with local communities to gather important information that can help create better care and prevention strategies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Science Center NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project start | February 1, 2025 |
| Project end | January 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $487,386 |
| NIH project number | 1UG3AG090675-01 |
| Project ID | NIH-11035847 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals living in French-speaking Sub-Saharan Africa who are affected by Alzheimer's Disease or related dementias.
✕Less likely to help
Patients outside of French-speaking Sub-Saharan Africa or those not affected by dementia may not receive benefits from this research.
What this research studies
This research aims to enhance the understanding and treatment of Alzheimer's Disease and related dementias in French-speaking Sub-Saharan Africa. It focuses on building research capacities that consider the unique cultural and linguistic contexts of the region, which has been historically underserved in dementia research. By addressing barriers to access and gathering data on genetic and environmental factors, the project seeks to inform better intervention and prevention strategies for dementia. The approach includes collaboration with local communities and leveraging existing partnerships to ensure the research is relevant and impactful.
Why it matters
Potential benefit: If successful, this research could lead to improved access to care and tailored treatment strategies for individuals with dementia in French-speaking Africa.
How similar studies have gone: While there has been limited research specifically targeting dementia in this region, similar initiatives in other underserved areas have shown promise in improving health outcomes.
Where this research is happening
-
University of Texas Hlth Science Center
San Antonio, United States Active
Researchers
- Principal investigator: Fongang, Bernard — University of Texas Hlth Science Center
- Study coordinator: Fongang, Bernard
Related research
Other NIH-funded projects on the same topics.
-
Investigating how DNA damage and repair mechanisms are altered in ALS and frontotemporal dementia.
This study is looking at how problems with DNA repair might contribute to conditions like ALS and frontotemporal dementia, and it’s testing ways to fix these issues in cells from patients to help develop new treatments.
-
Synthetic protein mimetics to treat Lewy Body Dementia
A new therapeutic approach using engineered protein-like molecules to block the harmful protein clumps that cause Lewy Body Dementia.
-
Dementia care staff study: adapting a US survey for use in many countries
A study is adapting and testing a survey for dementia care workers in the US, Brazil, Switzerland, and Ghana to help understand why workers stay in their jobs and how to improve care.
-
Dementia care staff study: adapting a survey for use in many countries
A multinational study will adapt and test a U.S. dementia-care worker survey in Brazil, Switzerland, and Ghana to help understand why staff stay in or leave long-term care settings.
-
Study of Dementia Care Staff in 4 Countries: Adapting Caregiver Surveys Across Cultures
A multinational project will adapt and test a dementia care worker survey so researchers can compare care environments across the US, Brazil, Switzerland, and Ghana.
-
New biomarkers to distinguish LATE from Alzheimer’s disease in dementia
A study to develop blood and CSF tests that can tell apart LATE from Alzheimer’s disease in people with dementia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.